Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Survival of patients with BRCA1-associated breast cancer diagnosed in an MRI-based surveillance program.

Breast cancer research and treatment - 1 May 2013

Møller Pål, Stormorken Astrid, Jonsrud Christoffer, Holmen Marit Muri, Hagen Anne Irene, Clark Neal, Vabø Anita, Sun Ping, Narod Steven A, Mæhle Lovise

Abstract excerpt

We report the 5- and 10-year survival rate of women diagnosed with breast cancer in the context of an annual MRI-based surveillance program. In 2001, as part of a national initiative, women in Norway with a BRCA1 mutation were offered annual screening with breast MRI in addition to mammography. 802 women with a BRCA1 mutation were screened one or more times and followed for a mean of 4.2 years. As of December...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Breast Neoplasms
Share to Carcinoma, Ductal, Breast

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Carcinoma, Intraductal, Noninfiltrating

Share to Early Detection of Cancer

Share to Genes, BRCA1

Share to Magnetic Resonance Imaging

Share to Mammography

Share to Norway

Source

Identifiers

PMID: 23615785
DOI: 10.1007/s10549-013-2540-z

Genes

BRCA1

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Survival of patients with BRCA1-associated breast cancer diagnosed in an MRI-based surveillance program.PMID 23615785Read ↗

BRCA1-associated breast cancers present differently from BRCA2-associated and familial cases: long-term follow-up of the Dutch MRISC Screening Study.Semantic proximity Read ↗

Should we screen BRCA1 mutation carriers only with MRI? A multicenter study.Semantic proximity Read ↗

Survival benefit in women with BRCA1 mutation or familial risk in the MRI screening study (MRISC).Semantic proximity Read ↗

Characteristics, treatment, and outcome of breast cancers diagnosed in BRCA1 and BRCA2 gene mutation carriers in intensive screening programs including magnetic resonance imaging.Semantic proximity Read ↗

Update on screening breast MRI in high-risk women.Semantic proximity Read ↗

Update on screening breast MRI in high-risk women.Semantic proximity Read ↗

Prospective study of breast MRI in BRCA1 and BRCA2 mutation carriers: effect of mutation status on cancer incidence.Semantic proximity Read ↗

Triple-Negative versus Non-Triple-Negative Breast Cancers in High-Risk Women: Phenotype Features and Survival from the HIBCRIT-1 MRI-Including Screening Study.Semantic proximity Read ↗

MRI Surveillance and Breast Cancer Mortality in Women With BRCA1 and BRCA2 Sequence Variations.Semantic proximity Read ↗

Screening for hereditary breast cancer.Semantic proximity Read ↗

American Cancer Society guidelines for breast screening with MRI as an adjunct to mammography.Semantic proximity Read ↗

Prospective study of breast cancer incidence in women with a BRCA1 or BRCA2 mutation under surveillance with and without magnetic resonance imaging.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.